Alnylam Pharmaceuticals Inc ALNY:NASDAQ
RT Quote | Last NASDAQ LS, VOL From CTA | USD
137.40UNCH (UNCH)
Volume
70,034
Close
137.40
-1.48 (-1.07%)
Volume
414,403
52 week range
119.29 - 178.41
...
Loading . . .
- Open138.34
- Day High140.82
- Day Low136.09
- Prev Close138.88
- 52 Week High178.41
- 52 Week High Date01/26/21
- 52 Week Low119.29
- 52 Week Low Date10/30/20
Key Stats
- Market Cap16.12B
- Shares Out117.32M
- 10 Day Average Volume0.47M
- Dividend-
- Dividend Yield-
- Beta1.24
- YTD % Change5.72
KEY STATS
- Open138.34
- Day High140.82
- Day Low136.09
- Prev Close138.88
- 52 Week High178.41
- 52 Week High Date01/26/21
- 52 Week Low119.29
- 52 Week Low Date10/30/20
- Market Cap16.12B
- Shares Out117.32M
- 10 Day Average Volume0.47M
- Dividend-
- Dividend Yield-
- Beta1.24
- YTD % Change5.72
RATIOS/PROFITABILITY
- EPS (TTM)-7.45
- P/E (TTM)-18.43
- Fwd P/E (NTM)-21.49
- EBITDA (MRQ)-793.666M
- ROE (MRQ)-69.92%
- Revenue (MRQ)492.85M
- Gross Margin (MRQ)84.16%
- Net Margin (MRQ)-174.15%
- Debt To Equity (MRQ)18.82%
EVENTS
- Earnings Date04/29/2021
- Ex Div Date-
- Div Amount-
- Split Date-
- Split Factor-
Latest From Alnylam Pharmaceuticals Inc
There is no recent news for this security.
Latest From Our Partners
- Alnylam submits NDA for RNAi drug vutrisiran to FDASeeking Alpha